Lilly CFO Ashkenazi leaving to take job at Google parent Alphabet
Anat Ashkenazi was Lilly’s third-highest paid executive last year. She has worked at the company for 23 years, including as chief financial officer since 2021.
John Russell
Articles
New director for IU Indy bioscience institute sets precision medicine as major goal
James Lin, a biomedical researcher who has focused on new innovations for tissue engineering and regenerative medicine, will start his new job in Indianapolis on Aug. 26.
Community Health planning $335M hospital in Westfield
The 425,000-square-foot project will mark the Indianapolis-based health care system’s first hospital in Hamilton County.
2024 Innovation Issue: How automation can be a lifesaver
Lilly plans to outfit its Lebanon plants—now under construction—with the latest in robotic, digital manufacturing equipment that will do much of the work that a generation ago was done by humans.
Lilly seeks to build conference center on downtown HQ campus
Eli Lilly and Co. plans to build the center on an existing parking lot at its downtown campus, with the goal of hosting more of its global meetings in Indianapolis.
Elanco to launch product that reduces dairy cattle methane emissions
Elanco has called Bovaer a potential blockbuster, meaning it could ring up annual sales of at least $100 million.
Lilly’s huge expansion plan took place at record speed to reduce bottlenecks for Mounjaro, Zepbound
The company said the site footprint will not expand, but the company will fill in the property with more buildings and equipment. Manufacturing capacity will almost triple there.
Lilly to invest another $5.3B in Lebanon site to meet overwhelming demand for Mounjaro, Zepbound
Lilly said the new investment will allow it to hire 200 more workers at the complex, including engineers, scientists, and lab technicians, for a total of 900 full-time workers when it is fully operational.
Drugmaker Novartis to expand nuclear medicine factory near airport, creating 55 jobs
Novartis Manufacturing LLC told a committee of the City-County Council on Monday evening that it plans to spend up to $125 million to construct and equip a 79,000-square-foot-building for radiopharmaceutical manufacturing and distribution on the city’s west side.
Butler University to start four-year nursing program in 2025
The Indiana Board of Nursing has accredited the university to accept 48 students a year, meaning the program will have nearly 200 students when it is fully enrolled across four years.
Nuclear medicine booms in central Indiana
The roster of radiopharmaceuticals players in the Indianapolis area has surged in the past few years to include some of the world’s leading pharmaceutical companies, attracted by the potential for significant growth.
Lilly settles with spa selling knockoff versions of its popular diabetes, weight-loss drugs
In a series of lawsuits Lilly filed in September and October in federal court, the drugmaker had accused Totality Medispa of trademark infringement, false advertising, unfair competition and unfair trade practices.
Lilly girding for questions over Alzheimer’s treatment from FDA committee
The U.S. Food and Drug Administration is convening a panel of independent experts on June 10 to discuss donanemab’s safety and effectiveness, including the results in patients in a clinical trial.
Indiana hospital prices remain among highest in nation, report says
In response, Indiana Hospital Association President Brian Tabor said the Rand report “continues to paint a distorted view of health care in our state.”
New EPA rules target coal ash ponds for cleanup
For the first time, federal regulations will cover the nearly 50 dumps spread across 14 locations in Indiana that were previously exempted from cleanup provisions.
Indiana life sciences companies raised $5.5B in 2023, new report says
A report issued Monday by BioCrossroads says Indiana life sciences companies saw a decrease in capital and investments last year, but made a significantly higher contribution to the state’s economy than they did the previous year.
Patients on hunt for diabetes, obesity and weight-loss drugs
Lilly’s newest obesity and diabetes medicines, widely known as GLP-1 drugs, are drawing rave reviews from doctors, researchers and patients for their ability to safely and effectively control blood sugar and take off weight.
Surgeons from across the U.S. come to Indiana Spine Group to learn the latest techniques
The Carmel medical group is gaining a reputation as a training and education center. It holds courses for high school and college students in anatomy as well as surgeons going out on their own after residencies and fellowships.
Many Indiana hospitals struggling financially amid rising expenses, report says
More than four years after the start of the COVID-19 pandemic, many Indiana hospitals are still barely breaking even and their financial viability remains at risk, according to a report released Thursday morning by the Indiana Hospital Association.
Lilly sees quarterly profit jump 67% on demand for new weight-loss drugs
Doctors and pharmacies have reported huge demand for Mounjaro and Zepbound in recent months, causing widespread shortages of the popular drugs.